上转换荧光侧向流免疫法快速检测血清蛋白电泳样本中的达雷妥尤单抗
本研究设计并构建上转换荧光侧向流免疫层析试纸条,用于临床样本中达雷妥尤单抗(DARA)的半定量检测,并评估其检出限、动态范围和分析干扰。用43例SPEP阳性患者血清验证,结果与病历中DARA使用史完全一致,表明该试纸条性能满足澄清SPEP中DARA干扰的目的。
要点
- 上转换荧光LFA试纸条可半定量检测血清中DARA。
- 43例SPEP阳性血清检测结果与DARA用药史完全匹配。
- 该试纸条可作为SPEP中DARA干扰的独立客观确认工具。
核心结论
- 上转换荧光LFA试纸条的性能满足澄清SPEP结果中DARA干扰的目的。
- 该试纸条可作为临床样本中存在DARA的独立客观确认手段。
研究设计与样本
- 设计并构建上转换荧光LFA试纸条,用于临床样本中DARA的半定量检测。
- 评估试纸条的检出限、动态范围和分析干扰。
- 用43例SPEP阳性患者血清样本检测DARA,并与病历用药史比对。
主要发现
- 43例SPEP阳性患者血清的DARA检测结果与病历中DARA使用史完全一致。
临床怎么用
- 该试纸条可与标准SPEP设备配套,作为低成本快速现场检测来核查DARA干扰。
- 有助于改善涉及DARA的模糊SPEP结果解读,且不干预检验科现行SPEP工作流程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Daratumumab (DARA) is a commonly used monoclonal antibody (mAb) drug for the treatment of multiple myeloma (MM). Its appearance as a visible abnormal band in the γ-region of a serum protein electrophoresis (SPEP) gel may interfere with the SPEP result interpretation. With the advantages of portability and rapid testing capabilities, up-conversion fluorescence lateral-flow immunoassay (LFA) can be an ideal solution to detect DARA interference. METHODS: An up-conversion fluorescence LFA strip was designed and constructed to perform semi-quantitative DARA testing in clinical samples. The LFA strip test was evaluated for limit of detection (LOD), dynamic range, and analytical interference. RESULTS: To demonstrate the clinical utility of the LFA strip, 43 SPEP-positive patient serum samples were tested for the presence of DARA, and the results exactly matched the DARA usage history in patient medical records. CONCLUSIONS: The performance of the up-conversion fluorescence LFA strip meets the purpose of clarifying DARA interference in SPEP results. It may be used as an independent and objective confirmation of the presence of DARA in clinical samples. The LFA strip offers a cost-effective rapid on-site test to check for DARA interference alongside standard SPEP equipment, which significantly improves the interpretation of ambiguous SPEP results involving DARA, and does not intervene the current SPEP workflow in clinical laboratory practice.
引用
- Liu Y, Tao Y, Yeung PS, et al. An up-conversion fluorescence lateral-flow immunoassay for rapid detection of Daratumumab in serum protein electrophoresis clinical samples. Clin Chim Acta. 2024. PMID: 38636694. doi:10.1016/j.cca.2024.119677
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。